Literature DB >> 23178

Molecular pathology of Fabry's disease. Physical and kinetic properties of alpha-galactosidase A in cultured human endothelial cells.

D L Johnson, R J Desnick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 23178     DOI: 10.1016/0304-4165(78)90346-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


× No keyword cloud information.
  5 in total

1.  Enzyme therapy in Fabry disease: differential in vivo plasma clearance and metabolic effectiveness of plasma and splenic alpha-galactosidase A isozymes.

Authors:  R J Desnick; K J Dean; G Grabowski; D F Bishop; C C Sweeley
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

2.  Lysosomal alpha-galactosidase in endothelial cell cultures established from a Fabry hemizygous and normal umbilical veins.

Authors:  L Hasholt; S A Sørensen
Journal:  Hum Genet       Date:  1986-01       Impact factor: 4.132

3.  Lysosomal glycosphingolipid storage in chloroquine-induced alpha-galactosidase-deficient human endothelial cells with transformation by simian virus 40: in vitro model of Fabry disease.

Authors:  M Inagaki; T Katsumoto; E Nanba; K Ohno; S Suehiro; K Takeshita
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

4.  Establishment and characterization of Fabry disease endothelial cells with an extended lifespan.

Authors:  Jin-Song Shen; Xing-Li Meng; Raphael Schiffmann; Roscoe O Brady; Christine R Kaneski
Journal:  Mol Genet Metab       Date:  2007-07-17       Impact factor: 4.797

Review 5.  Ion channels and pain in Fabry disease.

Authors:  Carina Weissmann; Adriana A Albanese; Natalia E Contreras; María N Gobetto; Libia C Salinas Castellanos; Osvaldo D Uchitel
Journal:  Mol Pain       Date:  2021 Jan-Dec       Impact factor: 3.395

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.